The disturbance in the Force is due to Sanofi, the broken second leg of our three legged stool. Leg #1 is Prochymal, and while Health Canada and New Zealand have approved it, Sanofi clearly and defiantly stands in the way. The third leg is AMI, also tied to Sanofi by a $20 million phase 2 milestone never paid.
Biosurgery is a GIVEN, more or less. The Grafix phase 4 has nothing to do with ongoing sales expansion. Ovation is for bone repair.
QUESTION: Cartiform and Chondrogen appear to target the same indications. Are they slightly different?
Anyway, if Sanofi goes away and Abbott comes on board with plans for a MSC cardiac stent. This would be ideal. I have already described why this is a real possiblity: 1. Abbott almost partnered with Mesoblast for heart stem cells. 2. Stem cell on an absorbable stent are the next big thing.